share_log

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-K2 HealthVentures Equity Trust LLC(6.2%),Parag Shah(6.2%), etc.

Aslan Pharmaceuticals | SC 13G:超过5%持股股东披露文件-K2 HealthVentures Equity Trust LLC(6.2%),Parag Shah(6.2%)等

美股sec公告 ·  2023/03/20 17:20
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息